Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesisInt J Clin Pharmacol Ther, Publications Stolting, S., Klink, T., Bela, C., Engels, C., Wagner, T. Int J Clin Pharmacol Ther. 2004 Nov;42(11):652-3. http://www.ncbi.nlm.nih.gov/pubmed/15598036
